Autoimmune & Chronic Diagnosis Advocacy

Black women wait longer for diagnosis. The research is consistent across lupus, sarcoidosis, endometriosis, fibroids, thyroid disease, multiple sclerosis, scleroderma, rheumatoid arthritis, inflammatory bowel disease, and a long list of conditions whose presentation in our bodies has been under-studied, under-recognized, and under-treated. The delay is not individual. It is structural. And it is killing us slowly while we keep showing up to work, to family, to community as though everything is fine.

This network is a peer-support and advocacy circle for Black and African-diaspora women living with autoimmune and chronic diagnoses, fighting for diagnoses we do not yet have, and supporting each other through the navigation work that comes with both.

Membership includes women in every part of the disease arc. Women in the first months of unexplained symptoms — fatigue, joint pain, rash, menstrual irregularities, brain fog, GI symptoms — trying to figure out who to see and what to say. Women in the diagnostic process — running the tests, watching the lab values come in, navigating referrals to specialists. Women newly diagnosed and learning what their condition is. Women managing a stable disease course on a long-term treatment plan. Women in flare. Women in remission. Women supporting partners or family members through chronic illness.

What gets talked about. The clinical interactions that worked and the ones that did not. The primary-care provider who took the symptoms seriously and ran the right initial workup. The primary-care provider who attributed the fatigue to stress for three years before another doctor ran the basic labs that turned out to be markedly abnormal. The specialists who were thorough. The specialists who were dismissive. The scripts that have moved a stuck consultation into actual diagnostic work.

The diagnostic odyssey itself. The doctors we have fired. The doctors we have stayed with through frustration because they were the only ones accepting our insurance. The MyChart messages we have written and rewritten to be clear without sounding angry. The advocacy a partner or a friend or a sister has done in the exam room when our own voice was no longer landing.

The medications. The first-line treatments and the second-line treatments and the third-line treatments. The biologics and the infusion days. The side effects we tolerated and the side effects we could not. The medication-management work. The prior-authorization fights with insurance. The specialty-pharmacy logistics. The cost.

The work-life negotiation. The decision about whether to disclose a diagnosis to an employer. The accommodations we have asked for. The accommodations we have not asked for because we have done the math on what disclosure would cost us in promotion and project assignment. The long question of whether to step back from a demanding job and what that decision has done to our sense of self. The FMLA paperwork. The short-term disability claims. The long-term disability claims, in the cases where that has been the right path.

The family conversation. The partner who has shown up well and the partner who has not. The children who have grown up with a mother in active disease management and what we are teaching them about it. The extended family that has and has not understood. The cultural context in African and Caribbean families about chronic illness, suffering, and the framing of strength that has cost some of us a timely diagnosis.

The fertility and pregnancy conversation. The flare risk during pregnancy and postpartum. The medications that are and are not safe in pregnancy. The decision about whether to have children at all, given the diagnosis. The pregnancies that were planned around the disease and the pregnancies that were not. The postpartum flares.

The advocacy work. The patient-advocate organizations we have engaged with — some of which are doing real work, some of which are dominated by white voices and have not yet centered our experience. The research-participation conversations. The clinical-trial enrollment, the skepticism we have inherited about trial participation, the slow work of building trustworthy research infrastructures inside our own communities.

The mental health that always rides alongside chronic disease. The depression rates in chronic-disease populations. The anxiety that comes with flare-risk awareness. The grief for the body and the life we thought we were going to have. The therapists who understand chronic-illness adjustment and the therapists who do not.

Cadence: a daily channel for the flare-day questions and the medication-side-effect questions and the small specific things. A weekly long-form thread on one structural topic. A monthly virtual gathering. A quarterly session with a guest — a rheumatologist, an endocrinologist, a pelvic-pain specialist, a patient-rights attorney — for the questions that need a professional eye. Subgroups by condition: lupus, fibroids, endometriosis, thyroid, MS, IBD, and the long-undiagnosed-still-searching subgroup.

What we are not: a substitute for clinical care. A second-opinion service. A diagnostic forum.

What we are: the room that knows. The room where you do not have to explain your fatigue, your pain scale, or your decision to leave a job. The room where 'I am tired' is heard as a clinical statement and not as a complaint. The room that has watched its own members get the diagnoses they fought for and the room that holds the members who are still fighting. We are not letting any of us disappear into the diagnostic gap. That is the work.